Back to News
Market Impact: 0.2
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
Source: businesswire.com
Legal & LitigationHealthcare & Biotech
Hagens Berman is investigating claims in a class-action complaint brought by investors against PROCEPT BioRobotics (PRCT). The notice provides no allegations, damages figures, operating impact, or financial results, but introduces litigation risk for the medical-device company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
PRCT-0.85
More News
- California AG Says Paramount-WBD Merger Would Hurt the State
- Halozyme prices $1.3 billion convertible notes offering
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- UN fact-finding mission says US committed possible war crimes in Iran
- FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A
- Paramount is getting an assist from a key California pol as it defends its Warner merger against AG Rob Bonta